Digital communication in the pharmaceutical sector is developing rapidly – especially in direct exchanges with patients and healthcare professionals (HCPs). WhatsApp is playing an increasingly important role: fast, trusted, and ubiquitous. But with this opportunity comes greater responsibility. As soon as patients share information or ask questions, WhatsApp becomes a relevant source for potential suspected adverse drug reactions. This poses a challenge for your pharmacovigilance.
evalii®: Intelligent monitoring, immediate detection
evalii® is our specialized tool for automated monitoring of digital channels. It scans incoming posts and comments around the clock and documents them within seconds. A specially developed algorithm detects and channels messages with potentially PV-relevant content. Each identified message is manually reviewed by a trained pharmacovigilance agent and processed according to your specifications and in compliance with regulations.
Our quality assurance: trained, tested, certified
Security and compliance are at the heart of evalii®:
- Our pharmacovigilance staff undergo a certified training program and are regularly trained on legal requirements and internal SOPs.
- All processes are based on structured Standard Operating Procedures (SOPs) that can be audited at any time.
- evalii® operates according to an ISO 9001-certified quality management system. This means defined responsibilities, documented procedures, and continuous process optimization – for maximum traceability and quality assurance.
WhatsApp? Yes – but of course. With Comviira.
Many pharmaceutical companies already use WhatsApp – but often in the form of simple channels that offer no feedback or real interaction. But modern communication demands more: With Comviira WhatsApp becomes a true service and dialogue channel. Patients and HCPs can actively access content, ask questions, and, if desired, chat directly with service teams – in compliance with all legal requirements.
Why this is also legally relevant
As soon as you use WhatsApp for patient communication – for example, for inquiries about therapies, products, or side effects – potentially reportable content can arise. And this is precisely where the regulatory obligation comes into play: Relevant reports must be identified, documented, and processed via this channel as well. Without an integrated PV screening system like evalii®, you risk failing to comply with your reporting obligation – with all the resulting liability consequences. If you communicate there, you must also ensure that:
- relevant messages are reliably identified and processed,
- the documentation is complete,
- and your processes always comply with regulatory requirements.
Conclusion: Modern communication needs integrated security
WhatsApp is not an exception – it is a fully-fledged communication channel. Anyone who uses it must also consider the regulatory requirements. With evalii® and Comviira This can be done easily, efficiently and safely.
Interested? Feel free to contact us here – or by WhatsApp:
English 
German